In the wake of more stringent regulations for environmental testing introduced by the National Environmental Laboratory Accreditation Conference (NELAC) and the Environmental Protection Agency (EPA) in recent years, Nova required stronger compliance through record keeping, demonstration of capability (DOC), document control, reagent and standard traceability and reporting. Because its manual, paper-based system could no longer support this, Nova selected Thermo Scientific SampleManager LIMS integrated with the NextDocs DMS.
Nova offers diagnostic testing for the presence of infectious disease organisms, processing around 10,000 water samples each month to ensure compliance with the federal Safe Drinking Water Act (SDWA). In addition to helping Nova comply with regulatory requirements, Thermo Scientific SampleManager LIMS has also improved laboratory efficiencies and sample throughput, delivering significant cost and timesavings in Nova’s laboratory by automating previously lengthy, manual document management processes. 
Nova’s chief executive and founder Dr Pearce said: ‘Since its introduction into our laboratory, the SampleManager and NextDocs DMS solution has been instrumental in helping Nova maintain its NELAC accreditation in the state of Texas. The solution has also refined work processes and improved reporting to customers in terms of both quality and speed.’
Dave Champagne, vice president and general manager, Informatics at Thermo Fisher Scientific added: ‘By integrating Thermo Scientific SampleManager LIMS with NextDocs DMS, we are able to create a more comprehensive, personalised, seamless solution that works better together, offering greater benefit to our customers.’
                    
                
Pharma LIMS solution improves efficiency at Nova
Thermo Scientific system saves time and costs for Texan laboratory
You may also like
                                                                            Manufacturing
                                                
                            
                                
                            
                            
                Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025
Read moreThe company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
                                
                        
                    Trending Articles
You may also like
                                                            Manufacturing
                                                        
                                
                                                                            
                                                                    
                                
                    Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025
The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
                                                                    
                                
                            
                        You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.
                                                            Manufacturing
                                                        
                                
                                                                            
                                                                    
                                
                    Accelerating therapeutic manufacturing with smart and sustainable technologies
In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future